India to United States: Cetirizine Export Trade Route

The India to United States Cetirizine corridor is one of India's established pharmaceutical export routes, with 866 shipments documented worth a combined $36.7M USD. The route is dominated by DR.REDDY'S LABORATORIES LTD, which alone accounts for roughly 21% of all export value, reflecting the consolidated nature of India's cetirizine manufacturing sector.

Across 31 active suppliers, the average shipment value stands at $42.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with cetirizine's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 10.6%, placing it at rank #18 among India's top cetirizine export destinations globally.

On the import side, key buyers of Indian cetirizine in United States include GRANULES CONSUMER HEALTH, REED-LANE INC 359 NEW WARK,, RISING PHARMA HOLDINGS INC and 126 others. GRANULES CONSUMER HEALTH is the single largest importer with 56 shipments valued at $2.3M USD.

India's cetirizine exports to United States are driven primarily by a handful of large-scale manufacturers. DR.REDDY'S LABORATORIES LTD with 91 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 31 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — DR.REDDY'S LABORATORIES LTD, J B CHEMICALS AND PHARMACEUTICALS LIMITED, GRANULES INDIA LIMITED — together account for 45% of total trade value on this route. The average shipment value of $42.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as levocetirizine dihydrochloride tablets usp 5mg 10000s total qty 2770 x 10000s 27700000 nos and levocetirizine dihydrochloride tablets usp 5mg 10000s (3063 x 10000s packs=30630000 nos), suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, GRANULES CONSUMER HEALTH is the largest importer with 56 shipments worth $2.3M USD — representing 6% of all cetirizine imports from India on this route. A total of 129 buyers are active on this corridor.